LANZHOU FOCI PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.43 CNY | +1.23% |
|
+2.48% | -23.79% |
| Apr. 10 | Lanzhou Foci Pharmaceutical Chairman Resigns | MT |
| Apr. 09 | LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 1.02B 141M | Sales 2023 | 1.16B 161M | Capitalization | 4.98B 688M |
|---|---|---|---|---|---|
| Net income 2022 | 106M 14.64M | Net income 2023 | 67M 9.26M | EV / Sales 2022 | 4.34 x |
| Net cash position 2022 | 344M 47.48M | Net cash position 2023 | 353M 48.82M | EV / Sales 2023 | 3.98 x |
| P/E ratio 2022 |
45
x | P/E ratio 2023 |
74.1
x | Employees | - |
| Yield 2022 |
0.54% | Yield 2023 |
0.31% | Free-Float | 34.04% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.23% | ||
| 1 week | +2.48% | ||
| Current month | -7.59% | ||
| 1 month | -8.61% | ||
| 3 months | -5.83% | ||
| 6 months | -22.04% | ||
| Current year | -23.79% |
1 week
7.08
7.50
1 month
6.798.22
Current year
5.8410.15
1 year
5.8414.94
3 years
5.8415.17
5 years
5.8415.17
10 years
5.2727.20
| Managers | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 60 | 17-06-29 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 22-12-01 |
Li Jun Wu
BRD | Director/Board Member | 50 | 91-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guo Xian Bao
BRD | Director/Board Member | 69 | 22-05-11 |
Xin Min Zhao
BRD | Director/Board Member | 54 | 20-01-01 |
Guo Lin Chai
PRN | Corporate Officer/Principal | 57 | 99-12-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 7.43 | +1.23% | 3 677 500 |
| 24-04-24 | 7.34 | +0.82% | 2,884,700 |
| 24-04-23 | 7.28 | +1.53% | 4,186,200 |
| 24-04-22 | 7.17 | +0.14% | 4,370,250 |
| 24-04-19 | 7.16 | -0.42% | 2,345,915 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
LanZhou Foci Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs and large health products. The Companyâs main products are categorized into pills, tablets, granules, syrups, capsules, glue and others, including Liuwei Dihuang pills, Xiaoyao Pill, Xiangsha Yangwei pills, ginseng Gubeng Huanhao pills and other Chinese patent drugs, as well as large health products, such as Ejiao and Ejiao loafs. The Company distributes its products under the brand names Foci, Baolu and Mianshan. The Company is also involved in the cultivation, processing and marketing of Chinese herbal medicine. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-30
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -23.79% | 517M | |
| +37.37% | 6.05B | |
| -15.69% | 4.45B | |
| -12.46% | 3.06B | |
| -0.12% | 3.04B | |
| +0.47% | 2.58B | |
| +36.06% | 1.79B | |
| +0.84% | 1.66B | |
| -10.60% | 1.63B | |
| -12.03% | 1.54B |
- Stock Market
- Equities
- 002644 Stock
